Efficacy and Safety of Androgen-Deprivation Therapy Combined with Docetaxel Plus Prednisone in High-Burden Metastatic Hormone-Sensitive Prostate Cancer

Overview of attention for article published in Cancer Management and Research, June 2020

Altmetric Badge

Mentioned by

twitter: 1 X user

Citations

dimensions_citation: 2 Dimensions

Readers on

mendeley: 6 Mendeley

Summary X Dimensions citations

So far, Dimensions has found 2 publications that cite this research output.

2

The most recent citing publications are shown below. View all 2 publications that cite this research output on Dimensions.

siRNA-based approaches for castration-resistant prostate cancer therapy targeting the androgen receptor signaling pathway

Article in Future Oncology (September 2023)

Efficacy of androgen deprivation therapy combined with docetaxel chemotherapy in high-volume disease metastatic hormone-sensitive prostate cancer

Article in Chinese Journal of Experimental Surgery (December 2021)